Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for I-Sens Inc. (099190:KRX), powered by AI.
I-Sens Inc. is currently trading at ₩16,750. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for I-Sens Inc. on Alpha Lenz.
I-Sens Inc.'s P/E ratio is -93.6.
“I-Sens Inc. trades at a P/E of -93.6 (undervalued) with modest ROE of -1.6%.”
Ask for details →I-Sens Inc. is a leading enterprise in the medical technology sector, particularly renowned for its development and production of diagnostic devices aimed at improving diabetic care. The company's core product line includes blood glucose monitoring systems that cater to both personal and clinical settings, facilitating precise and timely measurement of glucose levels for effective diabetes management. I-Sens's flagship products are designed to provide accurate, reliable, and user-friendly solutions, empowering patients and healthcare providers through enhanced monitoring capabilities. Beyond diabetes care, I-Sens Inc. also focuses on expanding its portfolio to broader areas of medical diagnostics. With a strong research and development backbone, I-Sens continuously strives to innovate within the healthcare technology space. Its presence in numerous international markets underscores its role in advancing global health standards and accessibility to essential diagnostic tools. I-Sens Inc. remains a pivotal player within the medical device industry, contributing significantly to the trends and developments that shape modern healthcare practices.
“I-Sens Inc. trades at a P/E of -93.6 (undervalued) with modest ROE of -1.6%.”
Ask for details →I-Sens Inc. (ticker: 099190) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $481.7B.
The current price is ₩16,750 with a P/E ratio of -93.55x and P/B of 1.53x.
ROE is -1.61% and operating margin is 2.50%. Annual revenue is $315.4B.